Surrey Heartlands

Joint Formulary & PAD

Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Covid-19 (Tixagevimab plus cilgavimab - Covid-19)

Records returned : 11 (on 29 May 2025 at 13:01:05). Return to search results for ' Covid-19 '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

CD

Controlled drug. Prescribing and/or storage requirements may apply

R

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Un

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Tixagevimab plus cilgavimab

Drug:

Tixagevimab plus cilgavimab

Indication :

Covid-19

Status :

Non Formulary

Formulations :

Intramuscular injection (IM)

Restrictions / Comments:

Important

Not recommended under NICE TA971

Formulary Status :

Primary Care

Primary Care

ASPH

ASPH

RSFT

RSFT

SASH

SASH

SABP

SABP

Links :

SPC

NFD1

2. Dexamethasone

Drug:

Dexamethasone

Indication :

Covid-19

Status :

Red

Formulations :

Injection
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

3. Hydrocortisone

Drug:

Hydrocortisone

Indication :

Covid-19

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

4. Molnupiravir

Drug:

Molnupiravir

Indication :

Covid-19

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service

Formulary Status :

Primary Care

Primary Care

ASPH

ASPH

RSFT

RSFT

SASH

SASH

SABP

SABP

Links :

SPC

5. Molnupiravir

Drug:

Molnupiravir

Indication :

Covid-19

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service

Formulary Status :

Primary Care

Primary Care

ASPH

ASPH

RSFT

RSFT

SASH

SASH

SABP

SABP

Links :

SPC

6. Nirmatrelvir with Ritonavir

Drug:

Nirmatrelvir with Ritonavir

Indication :

Covid-19

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

7. Prednisolone

Drug:

Prednisolone

Indication :

Covid-19

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

Drug:

Remdesivir

Indication :

Covid-19

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

Drug:

Sotrovimab

Indication :

Covid-19

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

10. Tocilizumab

Drug:

Tocilizumab

Indication :

Covid-19

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

Primary Care

ASPH

RSFT

SASH

SABP

SABP

Links :

SPC

11. Casirivimab and imdevimab

Drug:

Casirivimab and imdevimab

Indication :

Covid-19

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Important

Not recommended under NICE TA878

Formulary Status :

Primary Care

Primary Care

ASPH

ASPH

RSFT

RSFT

SASH

SASH

SABP

SABP

Links :

SPC

NFD1